A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 450 participants.
Also called NCT01193179
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 450 participants
- Sponsor
- Registry
-
NCT01193179
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01193179. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
- Condition
- Diabetes, Type 2
- Intervention (Drug)
- OPC-262
- Lead sponsor
- Kyowa Kirin Co., Ltd.
Record details
- Record id
cardio:ct-nct01193179- Content hash
cf4a28968c3cc21992fa9355b0d44f7d0f1a3f07effa72980b2fbebea8072253